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Abstract 
 
Background: There is no consensus regarding the minimum of joints that should be included 
in an ultrasound (US) scoring system to reliably assess for disease activity in rheumatoid 
arthritis (RA).  
Purpose: To assess whether simplified US protocols for hand examination are as informative 
as the examination of 22 joints in patients with RA, and to correlate the US parameters with 
disease activity (DAS-28). 
Material and Methods: This is a cross-sectional study of 224 RA patients stratified based on 
their DAS-28 scores and assessed using eight preselected US examination protocols, 
including 22, 18, 16, 14, 10, 8 and two different combinations of 4 joints, respectively.  
Results: We found a significant difference between different US hand scores regarding their 
ability to detect active inflammation and erosions. DAS-28 scores correlated very well with 
the Power Doppler (PD) scores generated by all eight US examination protocols (r=0.89-1, 
Page 1 of 47
http://mc.manuscriptcentral.com/srad Email:acta.radiologica@gmail.com
Acta Radiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
2 
 
P<0.05), irrespective of patients’ disease activity. Simplified US scores missed information 
on presence of PD in 20.6 - 40.2% patients (P<0.05), and misdiagnosed non-erosive hand RA 
in 12 - 38.4% patients (P<0.05), depending on the number of joints excluded from US hand 
examination. 
Conclusion: Preselected simplified US scores are less reliable in appreciating the disease 
burden when compared with an extended protocol for 22 joint US examination, raising 
clinicians' awareness regarding the need to comprehensively assess multiple hand joints to 
reliably rule out subclinical inflammation.  
Keywords: hand, ultrasound, Power Doppler ultrasound. 
 
Introduction 
RA is a chronic inflammatory condition associated with well-recognised inflammatory joint 
features, which are amenable to US examination. The use of US facilitated a significant 
progress in the early diagnosis of RA, enabling a better assessment of the disease activity, 
prognosis and response to different therapeutic interventions. The implementation of US 
scoring systems in addition to clinical examination could help standardising the way RA is 
monitored; however, based on local availability of US and sonographer expertise, different 
scoring systems have been used in clinical practice. Despite significant research progress in 
supporting the role of US in RA, no consensus was reached with regard to what scoring 
system is the most useful. The OMERACT US Task Force defined the US pathology 
associated with RA (1), which combines tendon, joint and bone abnormalities (1, 2). The 
presence of Power Doppler (PD) is recognized as a reliable objective measure of active joint 
inflammation (3).  Different semi-quantitative scoring systems are currently used for 
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assessing synovial hypertrophy (SH), joint effusion, tendon abnormalities and erosions (4), 
and protocols for hand and feet US examination are well-established (5). 
A recent systematic review of the scoring systems used to evaluate synovitis in RA found 
difficult to determine the least number of joints that needed to be assessed for a global US 
score (1). The purpose of our study was to investigate how much we can simplify the US 
examination of hands in RA, without compromising the ability of a certain US scoring 
system to evaluate the disease activity and damage associated with hand RA. The authors 
focused on the US examination of hands as this is the most commonly used in routine clinical 
practice.  
 
Material and Methods 
This is a real-life, cross-sectional study, which evaluated patients referred to our US 
rheumatology outpatient clinics, presenting with inflammatory sounding hand joint pains. 
The patients were referred based on clinician indication to have an US scan to help with 
identifying joint inflammation that was not confidently assessed clinically. We examined 604 
patients between Jan 2012 and August 2015. For each patient, a set of demographic, clinical 
and laboratory data were recorded at the time of the scan. Of 604 patients referred to our 
clinic, 224 patients with RA were included in the study analysis based on their final diagnosis 
made using the 2010 ACR/EULAR classification criteria, following complete investigations 
and revision of the clinical notes. Fig. 1 details the patient selection and stratification based 
on DAS-28 scores.  
This study evaluated the same set of reported outcomes and clinical and laboratory 
parameters for all the patients, to ensure homogeneity of the collected data. The following 
information was analyzed: disease duration (in months), hand tender joint count (TJC) and 
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swollen joint count (SJC), as well as a patient reported global disease assessment score 
(GVAS).  
Additional data about the high sensitivity C-reactive protein (hsCRP), erythrocyte 
sedimentation rate (ESR), presence of rheumatoid factor (RF), anti citrullinated cyclic 
peptides antibodies (ACPA) and anti-nuclear antibodies (ANA) were collected at the time of 
the scan (needed to exclude associated pathology).  
For each patient, a detailed record was compiled of their medication at the time of the US 
scan, including paracetamol and NSAIDs, disease-modifying drugs (DMARDs), biologic 
therapies and glucocorticoids, either oral or intramuscular depot injection.  
The US protocol examination used included the extensor tendons and 22 joint assessments 
(dorsal longitudinal and transverse views of wrists, including extensor tendons, metacarpo-
phalangeal – MCP joints, and proximal interphalangeal – PIP joints), as per our local clinic 
protocol. The same US examination protocol was used for each patient, irrespective of their 
hand symptoms. The US findings were scored according to the OMERACT scoring system 
(1). The hand US examination was performed by two clinicians (CC and LA) in the same 
session, and for each patient a consensus was obtained.  
We used a Logiq S8 US machine (GE Healthcare, Wauwatosa, Wisconsin, WI, USA), 
equipped with a multi-frequency linear matrix array transducer (6-15 MHz). B-mode and PD 
machine setting were optimized and standardized for all our patients' US examinations. The 
settings used were: B-mode frequency 11-15 MHz depending on the depth of the anatomical 
area, Doppler frequency 7.5-15, depending on the depth of anatomical area; Doppler gain 18-
20 dB, low wall filters and pulse repetition frequency around 800 Hz. In this study, we only 
used Power Doppler (PD) mode. 
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The information collected comprised the following US parameters: SH grade (graded 1-3), 
erosions (present/absent), PD signal (graded 1-3), joint effusion (present/absent), osteophytes 
(present/absent), and tendon abnormalities (PD signal present/absent) using the US definition 
of joint pathology as defined by the OMERACT group (2) (Fig. 2 exemplifies two MCP 
joints with different SH and PD grades). Well controlled disease was defined as PD score 
zero (including joints and tendons). 
To address our research question and assess how many joints would require scanning, and 
which joints are most likely to provide the answer as to whether or not there is active disease, 
we tested and compared the following scoring systems (bilateral examination): 
- 22 joints (MCPs, PIPs, wrists) 
- 18 joints (wrists, MCP 2-5 and PIP 2-5) 
- 16 joints (MCP 2-5 and PIP 2-5) 
- 14 joints (wrists, MCP 2-4 and PIP 2-4) 
- 10 joints (wrists, MCP 2-3 and PIP 2-3) 
- 8 joints (MCP 2-3 and PIP 2-3) 
- 4 joints (wrists +MCP5) 
- 4 joints (MCP 2-3) 
 
The above joint combination score was selected based on our experience of performing US 
examination of hands in more than 1000 patients, which identified that the most affected 
joints in RA were the wrists, MCP 2,3 and 5, and PIP 2 and 3 (unpublished observation).   
 
The SH grade 1 score was calculated as the total number of the joints with SH grade 1, the 
SH grade 2 score as the total number of the joints with SH grade 2, and the SH grade 3 score 
as the total number of the joints with SH grade 3 per patient. The total PD score was the sum 
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of all individual PD scores per patient, and the erosion score was calculated as the total 
number of erosions per patient.  
Data about active inflammation affecting tendons overlying the above mentioned joints were 
also collected and reported separately. The total grey scale scores and PD scores for joints 
were calculated as a sum of the individual scores for all the joints included in the US 
examination protocol the score refers to. The duration of the US examination was 
approximately 25 minutes/patient. This 22 joint protocol is used routinely in our US clinics, 
which have 30 minute slots for clinical and US examination of patients with RA.   
Descriptive statistics were used to characterize the RA population, and Student T test, Mann-
Whitney U and Kuskal-Wallis tests were implemented for the assessment of different 
parameters and US scoring systems (IBM SPSS Statistics 22, IBM Corporation, 1 New 
Orchard Road, Armonk, New York 10504-1722, US). A P-value of <0.05 was considered a 
statistically significant result. Spearman’s correlation coefficients were used to correlate 
permutations of pairs of US scores and the total PD scores with the disease activity, as 
assessed by the disease activity score assessing 28 joints (DAS-28).  
The data were collected as standard of practice. The study analyzed cross-sectionally the 
results of the US examinations of patients seen in our US clinics over a defined period of 
time.  No ethical approval or patient’s consent were required as no patient information was 
used for teaching or new intervention research. The results of our study analysis had no 
impact on the clinical management of patients and their confidentiality was maintained.  
 
Results 
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To characterize in detail our RA cohort, we stratified patients based on DAS-28 (ESR) 
assessment of disease activity (Table 1). Demographic parameters were similar among 
different disease activity groups. As expected, patients with higher disease activity scores had 
significantly higher TJC, SJC, ESR and GVAS, while the CRP levels were similar between 
different groups. Both objective and subjective parameters included in the DAS-28 composite 
score were significantly increased in patients with active disease compared to moderate or 
low disease activity groups and with the group in remission.  
There were no significant differences in the total US scores including the majority of US 
parameters, or in the disease duration or type of medication used (for both conventional and 
biologic DMARDs). The only significant difference was between the proportion of patients 
with SH grade 2 at the US examination of their hands, which was higher in patients with 
moderately-active and strongly-active RA (P<0.05) (Table 1). The SH grade 2 total score also 
correlated with the SJC (r=0.89, P<0.05).  
The comparative analyse of the above-mentioned US scores showed no significant 
differences between the ability of the pre-selected US scores to capture information regarding 
SH grade 2 and 3, and the total PD scores per patient; however, the proportion of patients 
with no active disease at the US examination differed significantly based on the number of 
joints included in the examination protocol (P<0.05) (Table 2). Similarly, different US scores 
varied significantly in their ability to assess the total erosion score per patient and the 
proportion of patients with erosions (P<0.05). By simplifying the US examination of the hand 
in RA patients, active RA was underdiagnosed in a proportion of 20.6 to 40.2% of patients; 
similarly, the erosive burden was underappreciated in 12 - 28.4% RA patients (Table 2). 
Strong correlations were found between the PD score generated by the 22 joint examination 
and all of the other US score combinations (r = 0.68 - 0.74, P<0.05). The scores that 
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correlated very strongly were those assessing 8, 10 and 14 joints (r = 0.92-0.96, P<0.05). The 
weakest correlation was found between the 8 and the 4 joint score (wrist and MCP 5 
bilaterally) (r=0.28, P<0.05) (Suppl. Table 1). 
The permutation comparisons between pairs of US scores related to their ability to detect the 
presence active joint inflammation found no significant differences between the total PD 
scores assessed by 8, 10, 12 and 16 joint US scores and 10, 12, 16 and 18 joint scores, 
respectively (Suppl. Table 2). Similarly, the total grey scale score (combining the total scores 
for SH grade 2 and 3) identified no significant differences between the permutation 
comparisons between the scores assessing 8, 10, 14, 16 and 18 joints (Suppl. Table 3). 
The analysis was also focused on correlating the total PD scores derived from all the pre-set 
US examination protocols with the DAS-28 scores in patients stratified based on their disease 
activity, to identify if certain US hand examination protocols can be used differentially in 
patients with active disease compared to patients in remission. All the total PD scores derived 
from the eight US examination protocols correlated very strongly with DAS-28 assessment, 
irrespective of how well the disease was controlled (r = 0.88-1, P<0.005). 
  
Discussion 
This is the first large cross-sectional study correlating different US examination protocols 
(derived from a 22-hand joint comprehensive score) with DAS-28 score in patients in RA, 
stratified based on their disease activity.  
Quantitative and semi-quantitative US scores have been previously compared in RA (3), and 
US examination have been found to be sensitive to therapeutic interventions (4-8). A 
comprehensive study comparing several US score systems in RA found that all were sensitive 
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to change when assessing the response of RA patients to adalimumab (9, 10). In addition, 
simplified US scores (including 6 or 12 joints) have previously been compared with extensive 
US protocol examinations (assessing 12, and 44 joints respectively), and showed good 
sensitivity to change in three separate studies (11-13). However, none of these studies 
stratified patients based on their disease activity scores or included RA patients based on the 
clinical indication to have an US scan, as it is the case with our study. The need to use a 
comprehensive US scoring system, capturing both active and chronic inflammatory changes 
for assessment of RA disease activity, is supported by the good correlation between US and 
MRI findings (8, 14). The presence of SH and PD signal was found to be associated with 
structural damage in RA (15), even in patients in clinical remission (16), and was associated 
with risk of flares (17, 18).  
The role and reliability of US in the disease activity assessment in patients with RA is 
supported by several studies (19-21).   
Previous studies reported good correlation between hand US scores and DAS-28 assessment 
using three different US scores (22, 23), result that was also replicated by our study, which 
included a larger number of joint combinations, and also assessed US parameters stratified 
based on the DAS-28 scores.   
Our comparative analysis of several US scoring systems showed that there is significant 
difference in terms of the equivalence of several US hand-scoring systems. Our study found 
that age, duration of symptoms, duration of disease, type of medication and total PD score 
generated by US examination of hands were not able to inform about the inclusion of patients 
in one specific disease activity group, as patients stratified based on DAS 28 scores had 
similar parameters.  
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In addition to previous studies, we have been interested in exploring the amount and 
significance of missed information related to the use of simplified US hand examination 
protocols. A significant proportion of patients have been diagnosed as having well-controlled 
or non-erosive hand RA by using US protocols limiting the number of joints examined (10.6 - 
40.2 % and 12-34.8%, respectively).  Our study found that the assessment of our preselected 
8, 10 and 14 joints captured comparable amounts of information regarding disease activity in 
RA (still misdiagnosing around 40% of patients as having well controlled disease, equivalent 
to PD score zero), while the two 4 joint scores missed significant information when compared 
to the others (around 60% patient were diagnosed in remission despite having active disease 
at least in one joint). The scores including 20 and 22 joints captured more information than 
the 8, 10 and 14 joint scores, even if all the eight US scores we explored correlated very well 
with the DAS-28 assessment. This is particularly relevant for our patient group, characterized 
by a small number of active joints and clinical indication to have an US scan to establish if 
their disease was well controlled or not. In this context, underdiagnosing active disease would 
have erroneously led to classifying our patients as being in remission. The clinical consensus 
is that we cannot predict which joints are the most likely to flare in patients with RA patients; 
therefore examining only the joints that previously flared using a patient-tailored US protocol 
is not justified.  
Even if a comprehensive hand joint score is time-consuming, it can provide significant 
additional information compared to a simplified score, as our study showed. As expected, all 
the scores correlated very well with each other, because they are derived from a 
comprehensive US hand score, while missing significant information proportional to the 
number of joints excluded from US examination. All the pre-selected US hand scores 
correlated with the disease activity scores, despite the fact that the patient groups stratified 
based on disease activity had similar median total PD scores. This showed that subclinical in 
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inflammation can be find in similar proportion in RA patients, irrespective of their degree of 
chronic joint changes that are likely to influence their DAS-28 score. 
Limitations: Our study did not have strict inclusion criteria: the patients were included based 
on clinical indication to exclude subclinical synovitis. Therefore, there is a significant 
selection bias, as the study did not capture patients with obvious active synovitis detected by 
clinical examination. In this particular clinical context, detection of active disease in at least 
one joint is clinically relevant, as US examination triggered treatment optimization to 
minimize joint damage (e.g. guided steroid injection targeting the active joints or escalation 
of therapy).  In conclusion, even if simplified US scores for hand assessment of RA disease 
activity can be useful in practice, by examining additional joints, clinicians are able to detect 
subclinical inflammation, which is not captured by the simplified US scores. If previously 
studies re-assured clinicians that various US examination protocols correlated well with the 
DAS-28 assessment or were sensitive to change following therapy, our study showed that a 
significant proportion of patients can be misclassified as having well-controlled or non-
erosive disease as a result of simplified US protocols.  Further studies, including large 
longitudinal cohorts, are needed to establish the smaller number of joints needed to be 
examined to minimize the risk of under detecting subclinical inflammation in patients with 
hand RA.  
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Figure legends: 
Figure 1. Flowchart of the study population. 
Figure 2: Examples of MCP joint grading: SH grade 3 and PD grade 2 (above), and SH grade 
2 and PD grade 3 (below). 
 
Table 1- Comparison between RA patient groups stratified based on their DAS 28 scores 
using the 22 joint US scoring system as detailed above (Kruskal-Wallis test, p<0.05 shows a 
significant difference between the patient groups). 
 
RA patients stratified 
based on disease activity 
DAS28 
>5.1 
DAS 28  
3.2-5.1 
DAS 28  
2.6-3.2 
DAS 28 
 <2.6 
P value 
Age 
Mean ± SD 
55.6 ± 13.8 53.2 ± 16. 54.2 ± 15.5 50.3 ± 15.3 P=0.44 
% Female 80.0 89.5 71.4 75.6 P=0.11 
Disease duration 
(months):  
Mean ± SD 
120.3 ± 107  111.7± 135 70.5 ± 58.4 95.4 ± 
169.9 
P=0.51 
% of patients on steroids 
at the time of the scan (all 
patients were on ≤ 10 mg 
daily)            
38 43.3 29.0 36.8 P=0.36 
% of patients on 
conventional DMARDs at 
the time of the scan            
74 54.2 64.5 65.8 P=0.11 
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% of patients on biologic 
treatment at the time of 
the scan            
24 19.3 29.0 26.3 P=0.67 
CRP  
Mean ± SD 
8.2 ± 10.8 6.1 ± 14.8 4.3 ± 7.9 4.3 ± 9.6 P=0.42 
ESR  
Mean ± SD 
31.1 ± 26.7 16.4 ± 15.1 11.5 ± 15.5 6.8 ± 6.7 P<0.05 
SJC  
Mean ± SD 
5.3 ± 4.6 2.4 ± 2.5 1.5 ± 1.9 0.5 ± 0.8 P<0.05 
TJC 
Mean ± SD 
17.1 ± 7.5 6.7 ± 5.2  4.5 ± 4.6 1.3 ± 2.0 P<0.05 
GVAS 
Mean ± SD 
74.6 ± 19.8 48.4 ± 26.4 34.4 ± 23.3 25 ± 26.2 P<0.05 
Mean DAS 28 score ± SD 5.9 ± 0.75 3.9 ± 0.5 2.9 ± 0.16 1.7 ± 0.6 P<0.05 
Total number of joints 
with SH grade 1 / patient 
Mean ± SD 
2.4 ± 3.1 2.6 ± 3.7 1.7 ± 2.7 1.2 ± 1.8 P=0.52 
Percentage of patients 
with joints with SH 
grade 1: 
58.0 66.3 51.6 47.4 P=0.23 
Total number of joints 
with SH grade 2 / patient 
Mean ± SD 
2.4 ± 3.4 2.2 ± 3.2 1.6 ± 4.4 1.3 ± 2.5 P=0.36 
Percentage of patients 
with joints with SH 
grade 2: 
58.0 53.0 48.4 29.0 P<0.05 
Total number of joints 
with SH grade 3 / patient 
Mean ± SD 
2.1 ± 2.8 1.2 ± 1.7 1.1 ± 2.1 0.7 ± 1.3 P=0.49 
Percentage of patients 
with joints with SH grade 
3: 
52.0 44.6 35.5 31.6 P=0.23 
PD score  1.9 ± 2.9 1.2 ± 2.4 1.1 ± 1.5 0.7 ± 1.3 P=0.58 
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Mean ± SD 
Percentage of patients 
with PD signal 
58.0 42.2 45.2 36.8 P=0.19 
Total number of joints 
with erosions / patient 
Mean ± SD 
6.5 ± 7.3 5.0 ± 5.5 4.3 ± 3.8 2.7 ± 4.1 P=0.17 
Percentage of patients 
with erosions: 
64.0 49.4 64.5 39.5 P=0.09 
Percentage of patients 
with tendon abnormalities  
(GS score ≥ 2) 
8.16 10.4 13.3 10.81 P=0.42 
Percentage of patients 
with active tenosynovitis 
 (PD score ≥ 1) 
6.12 5.81 8.13 10.81 P=0.13 
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Table 2: Comparison between 8 different US scores (P<0.05 was considered significant). 
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US findings/ 
scores 
22 joints  
 
(wrists, 
MCPs, 
PIPs) 
 
18 joints  
 
(wrists,  
MCP 2-5, 
PIP 2-5) 
16 joints  
 
(MCP 2-5, 
PIP 2-5) 
14 joints 
 
(wrists, 
MCP 2-4, 
PIP 2-4) 
10 joints 
 
(wrists, 
MCP2-3, 
PIP 2-3)  
8 joints 
 
(MCP2-3,  
PIP 2-3) 
4 joints 
 
(wrists, 
MCP5) 
4 joints  
 
(MCP 2-3 
bilaterally) 
P value 
SH grade 2 
score /patient  
Median: 0 
IQR: 3 
Median: 0 
IQR:1 
Median: 0 
IQR:1 
Median: 0 
IQR: 1 
Median: 0 
IQR: 1 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
Median: 0 
IQR:1 
- 
Mean SH 
grade 2 score 
± SD: 
2 ± 3.21 1.19 ± 2.32 0.9 ± 1.83 0.71 ± 1.4 0.7 ± 1.39 0.15 ± 0.4 0.43 ±0.92 1.19 ±2.32 0.43 
Percentage of 
patients with 
no evidence 
of SH grade 
2: 
51.8 64.3 64.3 66.5 69.6 69.6 89.3 76.8 0.15 
SH grade 3 
score /patient  
Median: 0 
IQR: 2 
Median: 0 
IQR:1 
Median: 0 
IQR:1 
Median: 0 
IQR:1 
Median: 0 
IQR: 1 
Median: 0 
IQR: 1 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
- 
Mean  SH 
grade 3 score 
± SD: 
1.3 ± 2.08 0.71 ±  1.41 0.7 ± 1.40 0.58 ±1.17 0.5 ± 0.97 0.5 ± 0.95 0.09 ±0.34 0.35±0.74 0.15 
Percentage of 
patients with 
no evidence 
of SH grade 
3: 
57.1 69.2 69.2 71.4 74.1 74.1 93.3 77.7 0.15 
PD 
score/patient  
Median: 0 
IQR: 2 
Median: 0    
IQR:1 
Median: 0    
IQR:1 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
- 
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Mean PD 
score ± SD: 
1.28 ± 2.31 0.69 ± 1.68 0.66 ± 1.66 0.61 ± 1.39 0.48 ±1.1 0.45 ± 1.07 0.09 ±0.36 0.32 ± 0.76 0.15 
Percentage of 
patients with 
well 
controlled 
hand RA (PD 
score = 0) 
54.0 74.6 75.9 75.4 77.7 79.0 94.2 81.3 
 
 
 
< 0.05 
Percentage of 
patients 
misdiagnosed 
with well 
controlled 
disease by the 
simplified US 
scores 
N/A 20.6 21.9 21.4 23.7 25 40.2 27.3 <0.05 
Erosion 
score/patient  
Median: 2 
IQR: 7.75 
Median: 1 
IQR: 4 
Median: 1 
IQR: 4 
Median: 1 
IQR:4 
Median: 1 
IQR: 3 
Median 
IQR:3 
Median: 1 
IQR:1 
Median:  1 
IQR:2 
< 0.05 
Percentage of 
patients with 
non-erosive 
hand RA: 
30.4 42.4 42.4 46.9 46.9 46.9 68.8 55.4 <  0.05 
Percentage of 
patients 
misdiagnosed 
with non-
erosive hand 
RA by the 
N/A 12 12 16.5 16.5 16.5 38.4 25 < 0.05 
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simplified US 
scores 
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Suppl. Table 1: Permutation correlations between pairs of US scoring systems assessing the 
total PD score (Spearman’s correlation rank test, P<0.05 shows significant correlation). 
Joints with  PD  22 joints 18 joints 
(wrists + MCP 
2-5, PIP 2-5) 
16 joints 
(MCP 2-5, 
PIP 2-5) 
14 joints 
(wrists + 
MCP 2-4, 
PIP 2-4) 
10 joints 
(wrists MCP 
2-3, PIP 2-3) 
8 joints 
(MCP 2-3,  
PIP 2-3) 
4 joints 
(wrists 
+MCP5) 
4 joints 
(MCP 2-3 
bilaterally) 
4 joints   
(MCP 2-3) 
r = 0.64 
P <0.05 
r =0. 85 
P <0.05 
r = 0.87 
P ≤ 0.05 
r = 0.87 
P ≤ 0.05 
r = 0.91 
P ≤ 0.05 
r = 0.94 
P ≤ 0.05 
r =0.29 
P ≤ 0.05 
- 
4 joints  
(wrists, MCP5) 
r = 0.37 
P ≤ 0.05 
r = 0.48 
P ≤ 0.05 
r = 0.36 
P ≤ 0.05 
r = 0.44 
P ≤ 0.05 
r = 0.41 
P ≤ 0.05 
r = 0.28 
P ≤ 0.05 
- r =0.29 
P ≤ 0.05 
8 joints 
(MCP2-3,  PIP 
2-3) 
r = 0.68 
P ≤ 0.05 
r = 0.90 
P ≤ 0.05 
r = 0.93 
P ≤ 0.05 
r = 0.92 
P ≤ 0.05 
r = 0.96 
P ≤ 0.05 
- r = 0.28 
P ≤ 0.05 
r = 0.94 
P ≤ 0.05 
10 joints 
(wrists, MCP 2-
3, PIP 2-3) 
r = 0.69 
P ≤ 0.05 
r = 0.93 
P=<0.05 
r = 0.90 
P ≤ 0.05 
r = 0.96 
P ≤ 0.05 
- r = 0.96 
P ≤ 0.05 
r = 0.41 
P ≤ 0.05 
r = 0.91 
P ≤ 0.05 
14 joints 
(wrists, + MCP 
2-4,  PIP 2-4) 
r = 0.72 
P ≤ 0.05 
r = 0.98 
P ≤ 0.05 
r = 0.95 
P ≤ 0.05 
- r = 0.96 
P ≤ 0.05 
r = 0.92 
P ≤ 0.05 
r = 0.44 
P ≤ 0.05 
r = 0.87 
P ≤ 0.05 
16 joints  
(MCP 2-5, PIP 
2-5) 
r = 0.73 
P≤ 0.05 
r =0.97 
P ≤ 0.05 
- r = 0.95 
P ≤ 0.05 
r = 0.90 
P ≤ 0.05 
r = 0.93 
P ≤ 0.05 
r = 0.36 
P ≤ 0.05 
r = 0.87 
P ≤ 0.05 
18 joints 
(wrists + MCP 
2-5, PIP 2-5) 
r = 0.74 
P ≤ 0.05 
- 
 
r =0.97 
P ≤ 0.05 
r = 0.98 
P ≤ 0.05 
r = 0.93 
P=<0.05 
r = 0.90 
P ≤ 0.05 
r = 0.48 
P ≤ 0.05 
r = 0. 85 
P ≤ 0.05 
22 joints 
- r = 0.74 
P ≤ 0.05 
r = 0.73 
P≤ 0.05 
r = 0.72 
P ≤ 0.05 
r = 0.69 
P ≤ 0.05 
r = 0.68 
P≤ 0.05 
r = 0.37 
P ≤ 0.05 
r = 0.64 
P ≤ 0.05 
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Suppl. Table 2: Permutation comparisons between pairs of US scoring related to their ability 
to detect the presence of PD signal (P<0.05 shows significant difference between scores). 
 
Joints with  PD  22 joints 18 joints 
(wrists, 
MCP 2-5, 
PIP 2-5) 
16 joints ( 
MCP 2-5, 
PIP 2-5) 
14 joints 
(wrists, MCP 
2-4, PIP 2-4) 
10 joints 
(wrists, MCP 
2-3, PIP 2-3) 
8 joints 
(MCP 2-3, 
PIP 2-3 
4 joints 
(wrists, 
MCP5) 
4 joints  
(MCP 2-3 
bilaterally) 
4 joints (MCP 2-3) 
P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 - 
4 joints (wrists + MCP5) 
P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 - P<0.05 
8 joints  
(MCP2-3, PIP 2-3) 
P<0.05 P<0.05 0.056 0.09 0.38 - P<0.05 P<0.05 
10 joints  
(wrists + MCP 2-3,  
PIP 2-3) 
P<0.05 0.059 0.09 0.14 - 0.38 P<0.05 P<0.05 
14 joints  
(wrists + MCP 2-4,  
PIP 2-4) 
P<0.05 0.28 0.35 - 0.14 0.09 P<0.05 P<0.05 
16 joints  
(MCP 2-5, PIP 2-5) 
P<0.05 0.42 - 0.35 0.09 0.056 P<0.05 P<0.05 
18 joints  
(wrists + MCP 2-5,  
PIP 2-5) 
P<0.05 - 0.421 0.28 0.059 P<0.05 P<0.05 P<0.05 
22 joints 
- P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 
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Suppl. Table 3: Permutation comparisons between pairs of US scoring related to their ability 
to detect moderate-severe SH (P<0.05 shows significant correlations). 
 
Assessment of 
moderate-severe SH 
22 joints 18 joints  
 
(wrists, MCP 
2-5, PIP 2-5) 
16 joints  
 
(MCP 2-5, PIP 
2-5) 
14 joints  
 
(wrists, MCP 
2-4, PIP 2-4) 
10 joints  
 
(wrists, MCP 
2-3, PIP 2-3) 
8 joints  
 
(MCP2-3, 
PIP 2-3) 
4 joints 
 
 (wrists, 
MCP5) 
4 joints  
 
(MCP 2-3 
bilaterally) 
4 joints (MCP 2-3 
bilaterally) 
P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 - 
4 joints (wrists + 
MCP5) 
P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 - P<0.05 
8 joints (MCP2-3, 
PIP 2-3) 
P<0.05 P<0.05 P<0.05 P=0.077 P=0.91 - P<0.05 P<0.05 
10 joints (wrists + 
MCP 2-3, PIP 2-3) 
P<0.05 P=0.077 P<0.05 P=0.096 - P=0.91 P<0.05 P<0.05 
14 joints (wrists + 
MCP 2-4, PIP 2-4) 
P<0.05 0.09 0.105 - 0.0967  0.077 P<0.05 P<0.05 
16 joints (MCP 2-5, 
PIP 2-5) 
P<0.05 0.945 - 0.105 P<0.05 P<0.05 P<0.05 P<0.05 
18 joints (wrists + 
MCP 2-5, PIP 2-5) 
P<0.05 - 0.945 0.0902 0.077 P<0.05 P<0.05 P<0.05 
22 joints 
- P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 P<0.05 
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Diagnostic accuracy of simplified ultrasound hand examination 
protocols for detection of inflammation and disease burden in 
patients with rheumatoid arthritis 
 
Abstract: 
 
Background: There is no consensus regarding the minimum of joints that should be included 
in an ultrasound (US) scoring system to reliably assess for disease activity in rheumatoid 
arthritis (RA).  
Purpose: To assess whether simplified US protocols for hand examination are as informative 
as the examination of 22 joints in patients with RA, and to correlate the US parameters with 
disease activity (DAS-28). 
Material and Methods: This is a cross-sectional study of 224 RA patients stratified based on 
their DAS-28 scores and assessed using eight preselected US examination protocols, 
including 22, 18, 16, 14, 10, 8 and two different combinations of 4 joints, respectively.  
Results: We found a significant difference between different US hand scores regarding their 
ability to detect active inflammation and erosions. DAS-28 scores correlated very well with 
the Power Doppler (PD) scores generated by all eight US examination protocols (r=0.89-1, 
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P<0.05), irrespective of patients’ disease activity. Simplified US scores missed information 
on presence of PD in 20.6 - 40.2% patients (P<0.05), and misdiagnosed non-erosive hand RA 
in 12 - 38.4% patients (P<0.05), depending on the number of joints excluded from US hand 
examination. 
Conclusions: Preselected simplified US scores are less reliable in appreciating the disease 
burden when compared with an extended protocol for 22 joint US examination, raising 
clinicians' awareness regarding the need to comprehensively assess multiple hand joints to 
reliably rule out subclinical inflammation.  
Keywords: hand, ultrasound, Power Doppler ultrasound. 
 
Introduction 
RA is a chronic inflammatory condition associated with well-recognised inflammatory joint 
features, which are amenable to US examination. The use of US facilitated a significant 
progress in the early diagnosis of RA, enabling a better assessment of the disease activity, 
prognosis and response to different therapeutic interventions. The implementation of US 
scoring systems in addition to clinical examination could help standardising the way RA is 
monitored; however, based on local availability of US and sonographer expertise, different 
scoring systems have been used in clinical practice. Despite significant research progress in 
supporting the role of US in RA, no consensus was reached with regard to what scoring 
system is the most useful. The OMERACT US Task Force defined the US pathology 
associated with RA (1), which combines tendon, joint and bone abnormalities (1, 2). The 
presence of Power Doppler (PD) is recognized as a reliable objective measure of active joint 
inflammation (3).  Different semi-quantitative scoring systems are currently used for 
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assessing synovial hypertrophy (SH), joint effusion, tendon abnormalities and erosions (4), 
and protocols for hand and feet US examination are well-established (5). 
A recent systematic review of the scoring systems used to evaluate synovitis in RA found 
difficult to determine the least number of joints that needed to be assessed for a global US 
score (1). The purpose of our study was to investigate how much we can simplify the US 
examination of hands in RA, without compromising the ability of a certain US scoring 
system to evaluate the disease activity and damage associated with hand RA. The authors 
focused on the US examination of hands as this is the most commonly used in routine clinical 
practice.  
 
Material and Mmethods: 
This is a real-life, cross-sectional study, which evaluated patients referred to our US 
rheumatology outpatient clinics, presenting with inflammatory sounding hand joint pains. 
The patients were referred based on clinician indication to have an US scan to help with 
identifying joint inflammation that was not confidently assessed clinically. We examined 604 
patients between Jan 2012 and August 2015. For each patient, a set of demographic, clinical 
and laboratory data were recorded at the time of the scan. Of 604 patients referred to our 
clinic, 224 patients with RA were included in the study analysis based on their final diagnosis 
made using the 2010 ACR/EULAR classification criteria, following complete investigations 
and revision of the clinical notes. Fig.ure 1 details the patient selection and stratification 
based on DAS-28 scores.  
This study evaluated the same set of reported outcomes and clinical and laboratory 
parameters for all the patients, to ensure homogeneity of the collected data. The following 
information was analysedanalyzed: disease duration (in months), hand tender joint count 
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(TJC) and swollen joint count (SJC), as well as a patient reported global disease assessment 
score (GVAS).  
Additional data about the high sensitivity C-reactive protein (hsCRP), erythrocyte 
sedimentation rate (ESR), presence of rheumatoid factor (RF), anti citrullinated cyclic 
peptides antibodies (ACPA) and anti-nuclear antibodies (ANA) were collected at the time of 
the scan (needed to exclude associated pathology).  
For each patient, a detailed record was compiled of their medication at the time of the US 
scan, including paracetamol and NSAIDs, disease-modifying drugs (DMARDs), biologic 
therapies and glucocorticoids, either oral or intramuscular depot injection.  
The US protocol examination used included the extensor tendons and 22 joint assessments 
(dorsal longitudinal and transverse views of wrists, including extensor tendons, metacarpo-
phalangeal – MCP joints, and proximal interphalangeal – PIP joints), as per our local clinic 
protocol. The same US examination protocol was used for each patient, irrespective of their 
hand symptoms. The US findings were scored according to the OMERACT scoring system 
(1). The hand US examination was performed by two clinicians (CC and LA) in the same 
session, and for each patient a consensus was obtained.  
We used a Logiq S8 US machine (GE Healthcare, Medical Systems US and Primary Care 
Diagnostics, Wauwatosa, Wisconsin, WI, USA), equipped with a multi-frequency linear 
matrix array transducer (6-15 MHz). B-mode and PD machine setting were optimized and 
standardized for all our patients' US examinations. The settings used were: B-mode frequency 
11-15 MHz depending on the depth of the anatomical area, Doppler frequency 7.5-15, 
depending on the depth of anatomical area; Doppler gain 18-20 dB, low wall filters and pulse 
repetition frequency around 800 Hz. In this study, we only used Power Doppler (PD) mode. 
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The information collected comprised the following US parameters: SH grade (graded 1-3), 
erosions (present/absent), PD signal (graded 1-3), joint effusion (present/absent), osteophytes 
(present/absent), and tendon abnormalities (PD signal present/absent) using the US definition 
of joint pathology as defined by the OMERACT group (2) (Fig.ure 2 exemplifies two MCP 
joints with different SH and PD grades). Well controlled disease was defined as PD score 
zero (including joints and tendons). 
To address our research question and assess how many joints would require scanning, and 
which joints are most likely to provide the answer as to whether or not there is active disease, 
we tested and compared the following scoring systems (bilateral examination): 
- 22 joints (MCPs, PIPs, wrists) 
- 18 joints (wrists, MCP 2-5 and PIP 2-5) 
- 16 joints (MCP 2-5 and PIP 2-5) 
- 14 joints (wrists, MCP 2-4 and PIP 2-4) 
- 10 joints (wrists, MCP 2-3 and PIP 2-3) 
- 8 joints (MCP 2-3 and PIP 2-3) 
- 4 joints (wrists +MCP5) 
- 4 joints (MCP 2-3) 
 
The above joint combination score was selected based on our experience of performing US 
examination of hands in more than 1000 patients, which identified that the most affected 
joints in RA were the wrists, MCP 2,3 and 5, and PIP 2 and 3 (unpublished observation).   
 
The SH grade 1 score was calculated as the total number of the joints with SH grade 1, the 
SH grade 2 score as the total number of the joints with SH grade 2, and the SH grade 3 score 
as the total number of the joints with SH grade 3 per patient. The total PD score was the sum 
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of all individual PD scores per patient, and the erosion score was calculated as the total 
number of erosions per patient.  
Data about active inflammation affecting tendons overlying the above mentioned joints were 
also collected and reported separately. The total grey scale scores and PD scores for joints 
were calculated as a sum of the individual scores for all the joints included in the US 
examination protocol the score refers to. The duration of the US examination was 
approximately 25 minutes/patient. This 22 joint protocol is used routinely in our US clinics, 
which have 30 minute slots for clinical and US examination of patients with RA.   
Descriptive statistics were used to characterize the RA population, and Student T test, Mann-
Whitney U and Kuskal-Wallis tests were implemented for the assessment of different 
parameters and US scoring systems (IBM SPSS Statistics 22, IBM Corporation, 1 New 
Orchard Road, Armonk, New York 10504-1722, US). A P-value of <0.05 was considered a 
statistically significant result. Spearman’s correlation coefficients were used to correlate 
permutations of pairs of US scores and the total PD scores with the disease activity, as 
assessed by the disease activity score assessing 28 joints (DAS-28).  
The data were collected as standard of practice. The study analysedanalyzed cross-sectionally 
the results of the US examinations of patients seen in our US clinics over a defined period of 
time.  No ethical approval or patient’s consent were required as no patient information was 
used for teaching or new intervention research. The results of our study analysis had no 
impact on the clinical management of patients and their confidentiality was maintained.  
 
Results: 
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To characterisecharacterize in detail our RA cohort, we stratified patients based on DAS-28 
(ESR) assessment of disease activity (Table 1). Demographic parameters were similar among 
different disease activity groups. As expected, patients with higher disease activity scores had 
significantly higher TJC, SJC, ESR and GVAS, while the CRP levels were similar between 
different groups. Both objective and subjective parameters included in the DAS-28 composite 
score were significantly increased in patients with active disease compared to moderate or 
low disease activity groups and with the group in remission.  
There were no significant differences in the total US scores including the majority of US 
parameters, or in the disease duration or type of medication used (for both conventional and 
biologic DMARDs). The only significant difference was between the proportion of patients 
with SH grade 2 at the US examination of their hands, which was higher in patients with 
moderately-active and strongly-active RA (P<0.05) (Table 1). The SH grade 2 total score also 
correlated with the SJC (r=0.89, P<0.05).  
The comparative analyse of the above-mentioned US scores showed no significant 
differences between the ability of the pre-selected US scores to captur  information regarding 
SH grade 2 and 3, and the total PD scores per patient; however, the proportion of patients 
with no active disease at the US examination differed significantly based on the number of 
joints included in the examination protocol (P<0.05) (Table 2). Similarly, different US scores 
varied significantly in their ability to assess the total erosion score per patient and the 
proportion of patients with erosions (P<0.05). By simplifying the US examination of the hand 
in RA patients, active RA was underdiagnosed in a proportion of 20.6 to 40.2% of patients; 
similarly, the erosive burden was underappreciated in 12 - 28.4% RA patients (Table 2). 
Strong correlations were found between the PD score generated by the 22 joint examination 
and all of the other US score combinations (r = 0.68 - 0.74, P<0.05). The scores that 
Page 33 of 47
http://mc.manuscriptcentral.com/srad Email:acta.radiologica@gmail.com
Acta Radiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
8 
 
correlated very strongly were those assessing 8, 10 and 14 joints (r = 0.92-0.96, P<0.05). The 
weakest correlation was found between the 8 and the 4 joint score (wrist and MCP 5 
bilaterally) (r=0.28, P<0.05) (Suppl. Table 1). 
The permutation comparisons between pairs of US scores related to their ability to detect the 
presence active joint inflammation found no significant differences between the total PD 
scores assessed by 8, 10, 12 and 16 joint US scores and 10, 12, 16 and 18 joint scores, 
respectively (Suppl. Table 2). Similarly, the total grey scale score (combining the total scores 
for SH grade 2 and 3) identified no significant differences between the permutation 
comparisons between the scores assessing 8, 10, 14, 16 and 18 joints (Suppl. Table 3). 
The analysis was also focused on correlating the total PD scores derived from all the pre-set 
US examination protocols with the DAS-28 scores in patients stratified based on their disease 
activity, to identify if certain US hand examination protocols can be used differentially in 
patients with active disease compared to patients in remission. All the total PD scores derived 
from the eight US examination protocols correlated very strongly with DAS-28 assessment, 
irrespective of how well the disease was controlled (r = 0.88-1, P<0.005). 
  
Discussion 
In conclusion, Tthis is the first large cross-sectional study correlating different US 
examination protocols (derived from a 22-hand joint comprehensive score) with DAS-28 
score in patients in RA, stratified based on their disease activity.  
Quantitative and semi-quantitative US scores have been previously compared in RA (3), and 
US examination have been found to be sensitive to therapeutic interventions (4-8). A 
comprehensive study comparing several US score systems in RA found that all were sensitive 
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to change when assessing the response of RA patients to adalimumab (9, 10). In addition, 
simplified US scores (including 6 or 12 joints) have previously been compared with extensive 
US protocol examinations (assessing 12, and 44 joints respectively), and showed good 
sensitivity to change in three separate studies (11-13). However, none of these studies 
stratified patients based on their disease activity scores or included RA patients based on the 
clinical indication to have an US scan, as it is the case with our study. The need to use a 
comprehensive US scoring system, capturing both active and chronic inflammatory changes 
for assessment of RA disease activity, is supported by the good correlation between US and 
MRI findings (8, 14). The presence of SH and PD signal was found to be associated with 
structural damage in RA (15), even in patients in clinical remission (16), and was associated 
with risk of flares (17, 18). There was a good correlation between US findings and clinical 
examination in one study examining 60 joints/patient (19); however, there are obvious 
limitations to implement in practice such a comprehensive US protocol.  
The role and reliability of US in the disease activity assessment in patients with RA is 
supported by several studies (19-21).  It was previously proposed that a targeted US 
remission in early RA would inform clinicians better about the need of disease control 
optimisationoptimization compared to clinical assessment; however, this was not associated 
with long-term benefits in a recent randomisedrandomized controlled trial (22).  
Previous studies reported good correlation between hand US scores and DAS-28 assessment 
using three different US scores (23, 24), result that was also replicated by our study, which 
included a larger number of joint combinations, and also assessed US parameters stratified 
based on the DAS-28 scores.   
Our comparative analysis of several US scoring systems showed that there is significant 
difference in terms of the equivalence of several US hand-scoring systems. that can be used 
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in routine practice. Our study found that age, duration of symptoms, duration of disease, type 
of medication and total PD score generated by US examination of hands were not able to 
inform about the inclusion of patients in one specific disease activity group, as patients 
stratified based on DAS 28 scores had similar parameters. Only the proportion of patients 
with joints with SH grade 2 was different across different disease activity groups; however, 
this finding was no replicated in the case of severe SH (grade 3), disparity that can be 
explained by the lower number of patients with SH grade 3 included in our study.  
In addition to previous studies, we have been interested in exploring the amount and 
significance of missed information related to the use of simplified US hand examination 
protocols. A significant proportion of patients have been diagnosed as having well-controlled 
or non-erosive hand RA in our study by using US protocols limiting the number of joints 
examined (10.6 - 40.2 % and 12-34.8%, respectively).  Our study found that the assessment 
of our preselected 8, 10 and 14 joints captured comparable amounts of information regarding 
disease activity in RA (still misdiagnosing around 40% of patients as having well controlled 
disease, equivalent to PD score zero), while the two 4 joint scores missed significant 
information when compared to the others (around 60% patient were diagnosed in remission 
despite having active disease at least in one joint). The scores including 20 and 22 joints 
captured more information than the 8, 10 and 14 joint scores, even if all the eight US scores 
we explored correlated very well with the DAS-28 assessment. This is particularly relevant 
for our patient group, characterized by a small number of active joints and clinical indication 
to have an US scan to establish if their disease was well controlled or not. In this context, 
underdiagnosing active disease would have erroneously led to classifying our patients as 
being in remission. The clinical consensus is that we cannot predict which joints are the most 
likely to flare in patients with RA patients; therefore examining only the joints that previously 
flared using a patient-tailored US protocol is not justified.  
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In conclusion, Eeven if a comprehensive hand joint score is time-consuming, it can provide 
significant additional information compared to a simplified score, as our study showed. As 
expected, all the scores correlated very well with each other, because they are derived from a 
comprehensive US hand score, while missing significant information proportional to the 
number of joints excluded from US examination. All the pre-selected US hand scores 
correlated with the disease activity scores, despite the fact that the patient groups stratified 
based on disease activity had similar median total PD scores. This showed that subclinical in 
inflammation can be find in similar proportion in RA patients, irrespective of their degree of 
chronic joint changes that are likely to influence their DAS-28 score. 
Limitations: Our study did not have strict inclusion criteria: the patients were included based 
on clinical indication to exclude subclinical synovitis. Therefore, there is a significant 
selection bias, as the study did not capture patients with obvious active synovitis detected by 
clinical examination. In this particular clinical context, det ction of active disease in at least 
one joint is clinically relevant, as US examination triggered treatment optimization to 
minimize joint damage (e.g. guided steroid injection targeting the active joints or escalation 
of therapy).   
In conclusion, Our study concluded that even if simplified US scores for hand assessment of 
RA disease activity can be useful in practice, by examining additional joints, clinicians are 
able to detect subclinical inflammation, which is not captured by the simplified US scores. If 
previously studies re-assured clinicians that various US examination protocols correlated well 
with the DAS-28 assessment or were sensitive to change following therapy, our study showed 
that a significant proportion of patients can be misclassified as having well-controlled or non-
erosive disease as a result of simplified US protocols.  Further studies, including large 
longitudinal cohorts, are needed to establish the smaller number of joints needed to be 
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examined to minimiseminimize the risk of under detecting subclinical inflammation in 
patients with hand RA.  
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Figure legends: 
Figure 1. Flowchart of the study population. 
Figure 2: Examples of MCP joint grading: SH grade 3 and PD grade 2 (above), and SH grade 
2 and PD grade 3 (below) 
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Table 1- Comparison between RA patient groups stratified based on their DAS 28 scores 
using the 22 joint US scoring system as detailed above (Kruskal-Wallis test, p<0.05 shows a 
significant difference between the patient groups). 
 
RA patients stratified based on disease 
activity 
DAS28 
>5.1 
DAS 28  
3.2-5.1 
DAS 28  
2.6-3.2 
DAS 28 
 <2.6 
P value 
Age 
Mean ± SD 
55.6 ± 13.8 53.2 ± 16. 54.2 ± 15.5 50.3 ± 15.3 P=0.44 
% Female 80.0 89.5 71.4 75.6 P=0.11 
Disease duration (months):  
Mean ± SD 
120.3 ± 107  111.7± 135 70.5 ± 58.4 95.4 ± 169.9 P=0.51 
% of patients on steroids at the time of the 
scan (all patients were on ≤ 10 mg daily)           
38 43.3 29.0 36.8 P=0.36 
% of patients on conventional DMARDs 
at the time of the scan            
74 54.2 64.5 65.8 P=0.11 
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% of patients on biologic treatment at the 
time of the scan            
24 19.3 29.0 26.3 P=0.67 
CRP  
Mean ± SD 
8.2 ± 10.8 6.1 ± 14.8 4.3 ± 7.9 4.3 ± 9.6 P=0.42 
ESR  
Mean ± SD 
31.1 ± 26.7 16.4 ± 15.1 11.5 ± 15.5 6.8 ± 6.7 P<0.05 
SJC  
Mean ± SD 
5.3 ± 4.6 2.4 ± 2.5 1.5 ± 1.9 0.5 ± 0.8 P<0.05 
TJC 
Mean ± SD 
17.1 ± 7.5 6.7 ± 5.2  4.5 ± 4.6 1.3 ± 2.0 P<0.05 
GVAS 
Mean ± SD 
74.6 ± 19.8 48.4 ± 26.4 34.4 ± 23.3 25 ± 26.2 P<0.05 
Mean DAS 28 score ± SD 5.9 ± 0.75 3.9 ± 0.5 2.9 ± 0.16 1.7 ± 0.6 P<0.05 
Total number of joints with SH grade 1 / 
patient 
Mean ± SD 
2.4 ± 3.1 2.6 ± 3.7 1.7 ± 2.7 1.2 ± 1.8 P=0.52 
Percentage of patients with joints with 
SH grade 1: 
58.0 66.3 51.6 47.4 P=0.23 
Total number of joints with SH grade 2 / 
patient 
Mean ± SD 
2.4 ± 3.4 2.2 ± 3.2 1.6 ± 4.4 1.3 ± 2.5 P=0.36 
Percentage of patients with joints with 
SH grade 2: 
58.0 53.0 48.4 29.0 P<0.05 
Total number of joints with SH grade 3 / 
patient 
Mean ± SD 
2.1 ± 2.8 1.2 ± 1.7 1.1 ± 2.1 0.7 ± 1.3 P=0.49 
Percentage of patients with joints with SH 
grade 3: 
52.0 44.6 35.5 31.6 P=0.23 
PD score  
Mean ± SD 
1.9 ± 2.9 1.2 ± 2.4 1.1 ± 1.5 0.7 ± 1.3 P=0.58 
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Percentage of patients with PD signal 58.0 42.2 45.2 36.8 P=0.19 
Total number of joints with erosions / 
patient 
Mean ± SD 
6.5 ± 7.3 5.0 ± 5.5 4.3 ± 3.8 2.7 ± 4.1 P=0.17 
Percentage of patients with erosions: 64.0 49.4 64.5 39.5 P=0.09 
Percentage of patients with tendon 
abnormalities  
(GS score ≥ 2) 
8.16 10.4 13.3 10.81 P=0.42 
Percentage of patients with active 
tenosynovitis 
 (PD score ≥ 1) 
6.12 5.81 8.13 10.81 P=0.13 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Comparison between 8 different US scores (P<0.05 was considered significant). 
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US findings/ scores 22 joints  
 
(wrists, 
MCPs, 
PIPs) 
 
18 joints  
 
(wrists,  
MCP 2-5, 
PIP 2-5) 
16 joints  
 
(MCP 2-5, 
PIP 2-5) 
14 joints 
 
(wrists, 
MCP 2-4, 
PIP 2-4) 
10 joints 
 
(wrists, 
MCP2-3, 
PIP 2-3)  
8 joints 
 
(MCP2-3,  
PIP 2-3) 
4 joints 
 
(wrists, 
MCP5) 
4 joints  
 
(MCP 2-3 
bilaterally) 
P value 
SH grade 2 score 
/patient  
Median: 0 
IQR: 3 
Median: 0 
IQR:1 
Median: 0 
IQR:1 
Median: 0 
IQR: 1 
Median: 0 
IQR: 1 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
Median: 0 
IQR:1 
- 
Mean SH grade 2 
score ± SD: 
2 ± 3.21 1.19 ± 2.32 0.9 ± 1.83 0.71 ± 1.4 0.7 ± 1.39 0.15 ± 0.4 0.43 ±0.92 1.19 ±2.32 0.43 
Percentage of 
patients with no 
evidence of SH 
grade 2: 
51.8 64.3 64.3 66.5 69.6 69.6 89.3 76.8 0.15 
SH grade 3 score 
/patient  
Median: 0 
IQR: 2 
Median: 0 
IQR:1 
Median: 0 
IQR:1 
Median: 0 
IQR:1 
Median: 0 
IQR: 1 
Median: 0 
IQR: 1 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
- 
Mean  SH grade 3 
score ± SD: 
1.3 ± 2.08 0.71 ±  1.41 0.7 ± 1.40 0.58 ±1.17 0.5 ± 0.97 0.5 ± 0.95 0.09 ±0.34 0.35±0.74 0.15 
Percentage of 
patients with no 
evidence of SH 
grade 3: 
57.1 69.2 69.2 71.4 74.1 74.1 93.3 77.7 0.15 
PD score/patient  Median: 0 
IQR: 2 
Median: 0    
IQR:1 
Median: 0    
IQR:1 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
Median: 0 
IQR: 0 
- 
Mean PD score ± 
SD: 
1.28 ± 2.31 0.69 ± 1.68 0.66 ± 1.66 0.61 ± 1.39 0.48 ±1.1 0.45 ± 1.07 0.09 ±0.36 0.32 ± 0.76 0.15 
Percentage of 
patients with well 
controlled hand RA 
(PD score = 0) 
54.0 74.6 75.9 75.4 77.7 79.0 94.2 81.3 
 
 
 
< 0.05 
Percentage of 
patients 
misdiagnosed with 
well controlled 
disease by the 
simplified US 
scores 
N/A 20.6 21.9 21.4 23.7 25 40.2 27.3 <0.05 
Erosion 
score/patient  
Median: 2 
IQR: 7.75 
Median: 1 
IQR: 4 
Median: 1 
IQR: 4 
Median: 1 
IQR:4 
Median: 1 
IQR: 3 
Median 
IQR:3 
Median: 1 
IQR:1 
Median:  1 
IQR:2 
< 0.05 
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Percentage of 
patients with non-
erosive hand RA: 
30.4 42.4 42.4 46.9 46.9 46.9 68.8 55.4 <  0.05 
Percentage of 
patients 
misdiagnosed with 
non-erosive hand 
RA by the 
simplified US 
scores 
N/A 12 12 16.5 16.5 16.5 38.4 25 < 0.05 
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